日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The effects of a HEV-filtering contact lens on the brightness of natural images

高能可见光过滤隐形眼镜对自然图像亮度的影响

Hammond, Billy R; Buch, John R; Martin, Patricia; Shamp, Wright; Harth, Jacob B; Wysocky, Cameron; Renzi-Hammond, Lisa M

A Combination of Nicotinamide and D-Ribose (RiaGev) Is Safe and Effective to Increase NAD(+) Metabolome in Healthy Middle-Aged Adults: A Randomized, Triple-Blind, Placebo-Controlled, Cross-Over Pilot Clinical Trial

烟酰胺和D-核糖的组合(RiaGev)能安全有效地提高健康中年人的NAD(+)代谢组:一项随机、三盲、安慰剂对照、交叉试验性临床试验

Xue, Yongquan; Shamp, Trisha; Nagana Gowda, G A; Crabtree, Michael; Bagchi, Debasis; Raftery, Daniel

Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance

阿米卡星联合磷霉素治疗抗生素耐药性盛行的新生儿脓毒症

Christopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, Adam Johnson, Laura McEntee, Jennifer Unsworth, Ana Jimenez-Valverde, Silke Gastine, Ruwanthi Kolamunnage-Dona, Renata M A de Costa, Sally Ellis, François Franceschi, Joseph F Standing, Mike Sharland, Michael Neely, Laura Piddock, Shamp

The Li-F-H ternary system at high pressures

高压下的Li-FH三元体系

Bi, Tiange; Shamp, Andrew; Terpstra, Tyson; Hemley, Russell J; Zurek, Eva

Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects

两项随机、双盲、安慰剂对照、剂量递增的 I 期研究评估了 BTH1677(一种 1,3-1,6 β-葡聚糖病原体相关分子模式)在健康志愿者受试者中的疗效。

Halstenson, C E; Shamp, T; Gargano, M A; Walsh, R M; Patchen, M L

Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis

一项I期剂量递增研究,旨在评估替非巴珠单抗在需要血液透析的终末期肾病患者中的安全性和药代动力学特征。

Hetherington, Seth; Texter, Michele; Wenzel, Eric; Patti, Joseph M; Reynolds, Laurie; Shamp, Trish; Swan, Suzanne